SETD3 Acts as a Prognostic Marker in Breast Cancer Patients and Modulates the Viability and Invasion of Breast Cancer Cells
Scientific Reports - United Kingdom
doi 10.1038/s41598-020-59057-5
Full Text
Open PDFAbstract
Available in full text
Categories
Date
February 10, 2020
Authors
Publisher
Springer Science and Business Media LLC